|
2023
|
Invention
|
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators. The disclosure relates to modula... |
|
2022
|
Invention
|
Treating sickle cell disease with a pyruvate kinase r activating compound. Compounds that activat... |
|
|
Invention
|
Methods and compositions for inhibiting expression of ldha.
This disclosure relates to oligonucl... |
|
|
Invention
|
Activating pyruvate kinase r. The compound (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl... |
|
2021
|
Invention
|
Virus filtration of liquid factor vii compositions.
The present invention relates to a novel met... |
|
|
Invention
|
Activating pyruvate kinase r. This disclosure provides compounds and compositions for activating ... |
|
|
Invention
|
Stabilised compositions of factor vii polypeptides.
The invention relates to chemically as well ... |
|
|
Invention
|
Human coagulation factor vii polypeptides.
The present invention relates to novel human coagulat... |
|
2020
|
Invention
|
Therapeutic inhibition of lactate dehydrogenase and agents therefor. This invention relates to co... |
|
|
Invention
|
Pyruvate kinase r (pkr) activating compositions. The present disclosure provides crystalline soli... |
|
|
Invention
|
Methods and compositions for inhibiting expression of ldha. This disclosure relates to oligonucle... |
|
|
Invention
|
Stabilised solid compositions of factor vii polypeptides.
The invention relates to chemically as... |
|
|
Invention
|
Growth hormones with prolonged in-vivo efficacy.
The present invention relates to polypeptide co... |
|
2019
|
Invention
|
Growth hormones with prolonged in-vivo efficacy.
The invention relates to growth hormone compoun... |
|
|
Invention
|
Activating pyruvate kinase r. The disclosure provides novel chemical compounds useful as activato... |
|
|
Invention
|
Single-dose administration of factor viia.
The present invention provides methods for preventing... |
|
2018
|
Invention
|
Single dose administration of factor viia. The present invention provides methods for preventing ... |
|
|
Invention
|
Coagulation factor-targeting to trem-like transcript 1 (tlt-1) on activated platelets. Described ... |
|
|
Invention
|
Method of controlling a polypeptide modification reaction. The invention relates to a method of c... |
|
|
Invention
|
Coagulation factor vii polypeptides.
The present invention relates to modified coagulation Facto... |
|
2017
|
Invention
|
O-linked glycoforms of polypeptides and method to manufacture them. The present invention relates... |
|
|
Invention
|
Factor vii conjugates. The present invention relates to the conjugation of Factor VII polypeptide... |
|
2016
|
Invention
|
Transglutaminase mediated conjugation of peptides.
Methods for conjugating peptides are provided... |
|
2015
|
Invention
|
Coagulation factor ix conjugates.
The present invention relates to Factor IX polypeptides conjug... |
|
2014
|
Invention
|
Method for thioether conjugation of proteins. The invention relates to methods for obtaining a pr... |
